VWF and COVID-19: In severe cases, enhanced activation of the alternative complement pathway correlates with markers of endothelial injury (e.g. angiopoietin-2) and hypercoagulability (e.g., thrombomodulin and von Willebrand factor), highlighting complement activation as a defining feature of COVID-19 (46).